Product
Cellular therapy
1 clinical trial
5 indications
Indication
Allogeneic Stem Cell TransplantIndication
Acute Myeloid LeukemiaIndication
Myelodysplastic SyndromeIndication
Myeloproliferative NeoplasmIndication
Lymphoproliferative DisordersClinical trial
Preemptive Infusion of Donor Lymphocytes Depleted of TCR (Alpha-beta) + T Cells and CD19+ B Cells Following Allogeneic Stem Cell TransplantationStatus: Not yet recruiting, Estimated PCD: 2025-06-01